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Abstract
Background: Colonization by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has been
found to be markedly more common in HIV-infected individuals in the USA. Studies evaluating the prevalence
MRSA colonization in HIV-infected populations in Europe are scarce. The aim of this study was to investigate the
prevalence of MRSA colonization in a cohort of HIV-infected patients in Barcelona, Spain.
Methods: Nasal and pharyngeal S. aureus carriage was assessed in a random sample of 190 patients from an
outpatient HIV clinic. Nasal and pharyngeal swab specimens were obtained for staphylococcal culture from 190
and 110 patients respectively. All MRSA isolates were screened for Panton-Valentine leukocidin (PVL) genes by
PCR. Molecular characterization of MRSA isolates was performed by multilocus sequence typing. Data related to
HIV infection, healthcare exposure, and previously described risk factors for MRSA were collected from medical
records and a questionnaire administered to each patient.
Results: The patients’ characteristics were as follows: male, 83 %; median (IQR) age, 45 (39–49) years; intravenous
drug users, 39 %; men who have sex with men, 32 %; heterosexual, 26 %; CD4 count, 528/μL (IQR 351–740); on
antiretroviral therapy, 96 %; and undetectable plasma viral load, 80 %. Sixty-five patients (34 %) were colonized by
S. aureus. MRSA colonization was found in 1 % and 2 % of nasal and pharyngeal samples respectively. No PVL
positive MRSA strains were detected and all the MRSA isolates belonged to typical hospital-acquired clones.
Conclusions: Our data suggest that CA-MRSA colonization is not currently a problem in HIV-infected individuals
in our area.
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Background
Methicillin-resistant Staphylococcus aureus (MRSA) has
emerged as a causal agent of infection in individuals
without risk factors for healthcare- associated MRSA ac-
quisition that has been described as community-
associated MRSA (CA-MRSA) [1]. CA-MRSA infections
are usually distinguishable from their healthcare-related
counterparts by epidemiological, molecular, and clinical
features [2]. The incidence of the former is markedly in-
creased in certain population groups such as HIV-
infected patients, who have also been noted to have a
higher risk of CA-MRSA colonization [3, 4]. In addition,
HIV-infected individuals are frequently exposed to
healthcare environments, and related factors such as
prior hospitalization have also been linked to a higher
rate of MRSA colonization in this population [5]. Nasal
and extranasal MRSA colonization has been associated
with an increased risk of subsequent infections in both
HIV-negative and HIV-infected individuals [6, 7]. Add-
itionally, colonization might represent a reservoir for
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MRSA transmission. As HIV-infected patients are com-
monly exposed to healthcare settings, it is important to
assess the prevalence of colonization to determine the
need for preventive and control measures, at least in
hospital settings.
Most studies showing a high prevalence of MRSA
colonization among HIV-infected individuals have been
conducted in the USA. However, studies in certain US
regions [8] and Europe [5, 9–12] have reported low
prevalence.
Few European studies have evaluated MRSA colonization
or infection in the HIV-infected population [5]. The aim of
this study was to assess the prevalence of MRSA
colonization in a cohort of HIV-infected patients in Spain.
Methods
This is a cross-sectional study assessing S. aureus
colonization in a random sample of 190 adults
(>18 years) from a total of 1665 patients seen at an out-
patient HIV clinic in Barcelona, Spain between June
2011 and June 2012. Patients were randomly selected
using a statistical software package (IBM SPSS version
19.0, Chicago, IL). S. aureus colonization was investi-
gated by taking nasal swabs from all 190 patients and
pharyngeal swabs from 110 patients. Swabs were plated
onto MRSA agar medium (MRSA Select; Bio-Rad Labora-
tories, Madrid, Spain) and coagulase-mannitol salt agar
plates (BBL™ Coagulase Mannitol Agar; BD, Madrid, Spain),
and also inoculated into staphylococcal enrichment broth
(BBL brain-heart infusion; BD, plus 7 % NaCl). After 24 h
of incubation at 35-37 °C, the broths were subcultured onto
MRSA Select and coagulase-mannitol salt plates. All plates
were incubated for 48 h and inspected daily for S. aureus–
like colonies. S. aureus colonies were identified by latex ag-
glutination (Pastorex Staph-plus; Bio-Rad Laboratories) and
DNase production (DNase Test Agar; Difco, Fco. Soria
Melguizo, Madrid, Spain). Antibiotic susceptibility testing,
including cefoxitin, was performed by the disc-diffusion
method following CLSI recommendations [13]. All MRSA
isolates were screened for Panton-Valentine leukocidin
(PVL) genes by PCR. Molecular characterization of MRSA
isolates was performed by multilocus sequence typing and
SCCmec characterization as described previously [14, 15].
HIV infection–related data and epidemiological charac-
teristics previously described as community or healthcare-
related risk factors for MRSA were collected from medical
records and a questionnaire completed by each patient
(Table 1) [1].
CA-MRSA infection was defined according to the US
Centers for Disease Control and Prevention 2000 cri-
teria: 1) Diagnosis of MRSA in an outpatient setting or
by a culture positive for MRSA within 48 hours of
admission to hospital; 2) No medical history of MRSA
infection or colonization; and 3) No medical history in
the past year of: a) hospitalization; admission to a nursing
home, skilled nursing facility, or hospice; c) dialysis; d) sur-
gery; 4) permanent indwelling catheters or medical devices
that pass through the skin into the body [1]. Since
MRSA clones identified as typically CA-MRSA have
distinguishing genetic features from hospital-acquired
strains, such as SCCmec types IV and V and PVL ex-
pression, molecular characterization was also used to
ascertain the possible origin of the strains (community
vs healthcare environment) [2].
Table 1 Patient characteristics
(n = 190)
Age, y (median, IQR) 45 (39–49)
Sex (male/female) 158/32 (83 %/17 %)
HIV risk factor 74 (39 %)
IDU 61 (32 %)
MSM 49 (26 %)
Heterosexual 6 (3 %)
Other/unknown
AIDS 55 (29 %)
HCV 61 (32)
HBV 8 (4 %)
Current ART 182 (96 %)
CD4+ T cell count, cells/μL (median, IQR) 528 (351–740)
CD4+ T cell count, <200 cells/μL 19 (10 %)
HIV RNA, <40 copies/mL 153 (80 %)
Current use of TMP-SMX 15 (8 %)
Origin Delete
Spain 161 (85%)
Europe 1 (0.5%)
South America 19 (10%)
North Africa 4 (2%)
Sub-Saharan Africa 4 (2%)
Asia 1 (0.5%)
Risk factors for HA-MRSA acquisition
Antibiotic use in prior 12 months 70 (37 %)
Hospitalization in prior 12 months 32 (17 %)
Intravenous catheter use in prior 12 months 40 (21 %)
Surgical intervention in prior 12 months 19 (10 %)
Frequent visits (≥1 per week) to long-term
care facilities
17 (9 %)
Multiple sexual partners in prior 12 months 17 (9 %)
History of sexually transmitted infection 17 (9 %)
Previous incarceration 29 (15 %)
Data are shown as number (%) of patients unless otherwise indicated.
IDU, injecting drug user; IQR, interquartile range; HBV, hepatitis B virus; HCV,
hepatitis C virus; MSM: men who have sex with men;
TMP-SMX: trimethoprim-sulfamethoxazole
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Continuous variables are reported as medians and
interquartile range and categorical variables as numbers
and percentages. The former were compared using the
non-parametric Mann–Whitney U test while the latter
were compared using the Χ2 or Fisher’s exact test, with a
significance level of 0.05 (two-sided). A multivariate
logistic regression model including demographic character-
istics (age, gender, origin, HIV acquisition route), CD4+ T
cell count, viral load, use of ART, healthcare-related re-
lated risk conditions (recent hospitalization or admis-
sion to a nursing home, recent surgical intervention,
recent use of antibiotics), and other epidemiologic con-
ditions (history of incarceration, history of sexually
transmitted infections, multiple sexual partners) was
used to identify independent risk factors for S. aureus
and CA-MRSA colonization.
The study protocol was approved by the Clinical
Investigation Ethics Committee of Bellvitge University
Hospital and all patients gave written informed con-
sent prior to participation.
Results
The patients’ characteristics are summarized in Table 1.
There were no significant statistical differences between
patients with nasal and pharyngeal assessment (n = 110)
and those with nasal assessment only (n = 80) (data not
shown).
MRSA colonization was detected in 3 patients. Nasal
colonization was observed in 2/190 individuals (1 %) and
pharyngeal colonization in 2/110 individuals (2 %).
Among patients with nasal and pharyngeal samples
available, MRSA was present in both nasal and
pharyngeal samples in 1 subject whilst the other patient
was a pharyngeal carrier exclusively. Among those pa-
tients with MRSA colonization, two of them had risk
factors for nosocomial acquisition. The two isolates were
identified as ST146 and ST125, part of Clonal Complex
5 (CC5), and they both carried SCCmec IV (Table 2),
which are indistinguishable features from the dominant
hospital-acquired MRSA clone complex in our area [16].
The isolate belonging to the third patient was not
available for molecular studies but antibiotic suscepti-
bility and PVL results were available. Although the
patient had no apparent risk factors for hospital ac-
quisition, the antibiotic resistance pattern (resistance
to erythromycin and ciprofloxacin) was identical to
that of the dominant hospital-acquired MRSA lineage
(Table 2).
Colonization by methicillin-susceptible S. aureus (MSSA)
was documented in 62/190 nasal samples (32.6 %) and 3/
110 pharyngeal samples (2.7 %), with only 1 in 3 patients
found to be an exclusive MSSA pharyngeal carrier. None of
the risk factors analyzed, including those related to demog-
raphy, HIV acquisition route, HIV control, healthcare-
related conditions, and other epidemiologic conditions, was
statistically associated with MSSA colonization in either the
univariate or multivariate analyses.
Discussion
The prevalence of S. aureus colonization in our HIV-
infected population is consistent with rates reported for
the general population [17]. However, only 3 individuals
(corresponding to 2/190 nasal samples and 2/110
pharyngeal samples) were colonized by MRSA and none
of the isolates belonged to a typical CA-MRSA lineage.
Our data contrast with most reports from the USA, where
a significant association between HIV infection and MRSA
colonization has been well documented [3–7]. A recent
meta-analysis assessing MRSA colonization prevalence
and risk factors in HIV-infected individuals reported that
6.9 % of the population studied were MRSA carriers and
that this rate rose to 8.8 % when only studies from North
America were included [5]. Although data on MRSA car-
riage in HIV-infected individuals in Europe are scarce,
lower prevalence rates have been reported (0 % to 2.8 %)
[5, 9–12], and the findings in our series are consistent with
reports from other European studies.
Several US studies have described an association be-
tween CA-MRSA colonization and risk factors such as
sexual behavior, substance abuse, incarceration, and area
of residence [4, 6, 7]. These risk groups were represented
in our sample (Table 1).
We recently reported a series of MRSA infection in
HIV-infected patients in Spain in which we detected a
higher risk for MRSA infection among individuals with
poorly controlled HIV infection and immigrants (mostly
South Americans) [18]. Nevertheless, the overall preva-
lence was still lower than that reported for the USA.
The absence of CA-MRSA colonization in HIV-infected
individuals in our area could partly explain the low rate
of CA-MRSA infection in this population.
Table 2 Characterization of MRSA isolates
Patient Sample SCCmec MLST PVL Antibiotic resistance pattern
A Pharyngeal Type IV ST146 (CC5) Negative Resistance to: erythromycin, clindamycin, tobramycin and ciprofloxacin
B Nasal and Pharyngeal Type IV ST125 (CC5) Negative Resistance to: erythromycin, tobramycin and ciprofloxacin
C Nasal NA NA Negative Resistance to: erythromycin, tobramycin and ciprofloxacin
CC, clonal complex; MLST, multilocus sequence typing; PVL, Panton–Valentine Leukocidin; SCCmec, staphylococcal cassette chromosome mec; ST, sequence type
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Our study is the first to assess the prevalence of
MRSA colonization in HIV-infected patients in Spain.
However, it has some limitations. Although our sample
is representative of our cohort of HIV-infected patients,
the number of individuals studied is lower than in other
series. Additionally, while MRSA colonization of extranasal
areas such as the buttocks and the perianal, inguinal and
axillary regions has been well documented [4, 7, 19, 20], the
only extranasal location studied in our case was the phar-
ynx, and paired nasal and pharyngeal samples were only
available for a subset of 110 patients. Thus, the rate of
MRSA colonization in our cohort might have been under-
estimated. The importance of extranasal colonization has
been demonstrated for both hospital- and community-
acquired MRSA [4, 7, 19, 20]. Recent studies in the com-
munity setting have observed that nasal-only screening
could miss up to 51 % of MRSA colonized individuals
[4, 19]. In the subset of patients with both nasal and
pharyngeal samples in our series, MRSA was detected
in both samples in one patient while the other one was
an exclusive pharyngeal carrier. None of the patients had
exclusive nasal colonization in this subgroup. Although
we do not discount the importance of extranasal
colonization (the colonization rate would have been 50 %
lower if our study had been limited to nasal samples), the
rate of MRSA colonization in our cohort was low.
We were unable to genetically characterize one MRSA
isolate. However, PVL expression, which is characteristic
in CA-MRSA strains in our area, was not detected, and
the antibiotic susceptibility pattern, while unspecific, was
indistinguishable from the dominant hospital-acquired
MRSA lineage. Thus, the molecular characterization
results for the available isolates, the absence of PVL pro-
duction, and the antibiotic resistance patterns detected
suggested healthcare-related acquisition in all cases.
Conclusions
Although nasal and/or pharyngeal S. aureus colonization
was observed in one-third of HIV-infected patients in
our cohort, the prevalence of MRSA carriage was low
and colonization by typical CA-MRSA strains was not
observed. Thus, MRSA colonization in the HIV-infected
population in our area does not seem to be an epidemio-
logical problem requiring specific control strategies to
prevent cross-transmission and infection among HIV-
infected individuals. More studies are needed to assess
MRSA colonization rates in different European HIV-
infected populations.
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